ENANTA PHARMACEUTICALS INC (NASDAQ:ENTA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 11, 2026.
The Healthcare company reported Q0 revenue of .
ENANTA PHARMACEUTICALS INC's stock currently trades at $14.25 with a market capitalization of $301.9M.
